---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-009644"
form_type: "8-K"
ticker: "JAGX"
cik: "0001585608"
company_name: "Jaguar Health, Inc."
filed_at: "2026-01-12T23:59:59+00:00"
generated_at: "2026-05-16T10:52:20.680718+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Jaguar Health closes $350K private placement of 6% notes and warrants for working capital

## Summary
- Issued $350K aggregate principal of 6% unsecured promissory notes to accredited investors on Jan 6, 2026.
- Notes mature one month from issuance; prepayable without penalty.
- Investors received warrants to purchase up to 350K shares at $1.00/share, exercisable for 5 years.
- Proceeds used for working capital and general corporate purposes.
- Amendment corrects execution and closing dates in original 8-K from Jan 6 to Jan 6 (scrivener's error).

## SEC filing metadata
- accession: 0001193125-26-009644
- form_type: 8-K
- ticker: JAGX
- cik: 0001585608
- company_name: Jaguar Health, Inc.
- filed_at: 2026-01-12T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 1.01, 2.03, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1585608/000119312526009644/0001193125-26-009644-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1585608/000119312526009644/jagx-20260112.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-009644
- JSON: https://secwatch.observer/filing/0001193125-26-009644.json
- Plain text: https://secwatch.observer/filing/0001193125-26-009644.txt

## Key facts
- Debt Financings
  Jaguar Health, Inc. incurred senior notes of $350,000 at 6% per annum maturing one month after issuance.
  - Instrument: senior notes
  - Principal: $350,000
  - Rate: 6% per annum
  - Maturity: one month after issuance
  - Event: incurrence
  source text: On January 6, 2026 (the “Execution Date”), Jaguar Health, Inc. (the “Company”) entered into securities purchase agreements (the “Securities Purchase Agreements”) with two accredited investors (each, an “Investor”), pursuant to which the Company issued $350,000 aggregate principal amount of unsecured promissory notes (collectively, the “Notes”) to such Investors.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1585608/000119312526009644/0001193125-26-009644-index.htm
- Material Agreements
  Jaguar Health, Inc. entered into Securities Purchase Agreements with two accredited investors valued at $350,000 aggregate principal amount (effective 2026-01-06).
  - Action: entry
  - Agreement: equity purchase
  - Counterparty: two accredited investors
  - Value: $350,000 aggregate principal amount
  - Effective: 2026-01-06
  source text: On January 6, 2026 (the "Execution Date"), Jaguar Health, Inc. (the "Company") entered into securities purchase agreements (the "Securities Purchase Agreements") with two accredited investors (each, an "Investor"), pursuant to which the Company issued $350,000 aggregate principal amount of unsecured promissory notes (collectively, the "Notes") to such Investors.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1585608/000119312526009644/0001193125-26-009644-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.